Reading Hospital announced that Michael Kleinschmidt, PharmD, MBA, BCPS, DPLA, has been named Vice President of Operations, effective immediately.
In this role, he will have a particular focus on McGlinn Cancer Institute and oncology services, Central transport, inpatient and ambulatory pharmacy services, 340b program expansion, Environmental Services, Security, and Biomedical Engineering. He will report to Michelle Trupp, Senior Vice President and Chief Operating Officer for Reading Hospital.
Dr. Kleinschmidt joined the Reading Hospital and Tower Health team in November 2018 when he became Director of Pharmacy at the Hospital. Since then, he has taken on a series of increasing responsibilities, most recently as Senior Director of Support Services. He has served as a leader on multiple Hospital committees, including our Clinical Advisory Committee and Medication Safety Committee, which he chairs.
He earned his Doctor of Pharmacy from the University of the Sciences in Philadelphia and his Master of Business Administration – Healthcare Management from West Texas A&M University.
About Reading Hospital
Reading Hospital is the flagship, Magnet Recognized, acute care hospital of Tower Health. Located in West Reading, Pa., Reading Hospital is a 697-bed hospital that is home to many top-tier specialty care centers, including Reading HealthPlex, McGlinn Cancer Institute, Miller Regional Heart Center, Emergency Department, Level I Trauma Center, and Beginnings Maternity Center, which houses the region's only Level III Neonatal Intensive Care Unit (NICU). With more than 1,000 physicians, specialists, and advanced practice providers across 49 locations, Reading Hospital has been recognized for its quality outcomes and clinical expertise across service lines. It is listed as one of America's 100 Best Hospitals for four consecutive years (and moving up to America’s 50 Best Hospitals in 2022) and received a 5-Star Rating from CMS two years in a row. For more information, visit towerhealth.org.